北京市万商天勤律师事务所 关于 江苏蓝丰生物化工股份有限公司 2025 年第三次临时股东会 的法律意见书 北京市朝阳区建国门外大街 8 号北京国际财源中心 A 座 32 层 100022 电话: +86 10 82255588 www.vtlaw.cn 北京 深圳 上海 成都 武汉 西安 长沙 杭州 海口 南京 广州 香港(联营) 昆明 福州 北京市万商天勤律师事务所 关于江苏蓝丰生物化工股份有限公司 2025 年第三次临时股东会的 法律意见书 致：江苏蓝丰生物化工股份有限公司 根据《中华人民共和国证券法》《中华人民共和国公司法》及中国证券监督管理 委员会《上市公司股东会规则》（以下简称《股东会规则》）《深圳证券交易所上市 公司股东会网络投票实施细则》等法律、法规和规范性文件的规定，北京市万商天勤 律师事务所（以下称"本所"）接受江苏蓝丰生物化工股份有限公司（以下简称"公 司"）的委托，指派律师现场出席公司 2025 年第三次临时股东会，并出具法律意见。 本所律师同意将本法律意见书随公司本次股东会决议一并予以公告，并依法对本 法律意见书承担相应的责任。 本所律师根据《股东会规则》第六条的要求，按照律师行业公认 ...

证券代码：002513 证券简称：蓝丰生化 公告编号：2025-069 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、特别提示： 1、本次股东会未出现否决议案的情形。 2、本次股东会不涉及变更前次股东会决议。 二、会议召开情况 1、会议召开方式：本次股东会采用现场投票与网络投票相结合的方式。 2、召开时间 （1）现场会议召开时间为：2025 年 11 月 10 日（星期一）下午 14：50。 江苏蓝丰生物化工股份有限公司 2025 年第三次临时股东会决议公告 （2）网络投票时间为：2025 年 11 月 10 日。其中： ①通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 11 月 10 日 9：15～9：25、9：30～11：30、13：00～15：00； ②通过深圳证券交易所互联网投票系统投票的具体时间为：2025 年 11 月 10 日上午 9：15 至下午 15：00 期间的任意时间。 3、现场会议召开地点：安徽省滁州市中新苏滁高新技术产业开发区建业路 1 号旭合科技办公楼 202 会议室。 4、召集人：江苏蓝丰生物化工股份有限公司 ...

Investment Rating - The report maintains an "Outperform" rating for the chemical industry [3] Core Views - The macroeconomic data indicates a decline in the PMI to 49.0%, a decrease of 0.8 percentage points from the previous month. The main raw material purchasing price index also decreased by 0.7 percentage points [5][27] - The report highlights the need for the chemical industry to focus on high-end, green, intelligent, and circular development as emphasized in the recent policy recommendations from the Communist Party of China [5][51] - Investment strategies suggest focusing on sectors such as coal chemical, fluorochemical, phosphate and phosphorus chemical, and potassium fertilizer [5][61] Summary by Sections Macroeconomic Data - The October PMI is at 49.0%, down 0.8 percentage points from last month. The main raw material purchasing price index is at 52.5%, down 0.7 percentage points [27] - The PPI for September shows a year-on-year decline of 2.3%, with the decline narrowing by 0.6 percentage points from the previous month [5][27] - Fixed asset investment in the chemical raw materials and chemical products manufacturing sector saw a year-on-year decline of 5.6% in September, widening from the previous month [27] Downstream Industry Performance - In September, the export value of textile yarns and fabrics increased by 6.4% year-on-year, while the export value of household appliances decreased by 9.6% [42] - The production of new energy vehicles decreased by 2.4% year-on-year, while automobile production increased by 3.2% [42] Investment Recommendations - The report suggests focusing on the SW coal chemical, SW fluorochemical, SW phosphate and phosphorus chemical, and SW potassium fertilizer sectors for potential investment opportunities [61][62] - Recommended ETF: Penghua CSI Sub-Sector Chemical Industry Theme ETF (159870.SZ) [62]

Core Viewpoint - The photovoltaic industry is experiencing a significant upward movement in stock prices, driven by strategic initiatives among leading polysilicon companies to consolidate capacity and address accumulated industry debts [1][2]. Group 1: Market Performance - Stocks of polysilicon-related companies such as Gongsheng Silicon Industry, Yihua Co., and Lanfeng Biochemical have reached their daily limit, while companies like Silane Technology, Daqo New Energy, and Tongwei Co. have seen increases exceeding 8% [1]. Group 2: Industry Developments - Leading polysilicon companies are planning to form a consortium to eliminate excess capacity and settle industry debts, with total contributions expected to range between 20 billion to 30 billion yuan, although the total required funds for capacity storage will exceed this amount [1]. - The National Standardization Administration has released a notice regarding three mandatory national standards, including limits on energy consumption for polysilicon and germanium products, which will require new or expanded facilities to meet level 2 standards and existing facilities to comply with level 3 standards [1]. - Companies failing to meet the energy consumption benchmarks will face deadlines for rectification, with potential shutdowns for those that do not comply [1]. Group 3: Future Outlook - Zhongyuan Securities indicates that measures to combat internal competition, including product pricing strategies, mergers and acquisitions, increased industry entry barriers, and enhanced product quality standards, are expected to be implemented [2]. - The competitive landscape and ecosystem of the photovoltaic industry are anticipated to improve, presenting opportunities for valuation recovery [2]. - It is recommended to focus on leading companies within specific sub-sectors such as energy storage inverters, BC and perovskite batteries, encapsulants, photovoltaic glass, and polysilicon materials [2].

Core Viewpoint - The photovoltaic sector is experiencing a strong upward trend, particularly in the polysilicon segment, with multiple stocks hitting the daily limit up, indicating robust investor interest and market momentum [1] Group 1: Market Performance - Tongwei Co., Ltd. has reached the daily limit up, reflecting strong market performance [1] - Other companies such as Hoshine Silicon Industry, Yichin Photovoltaic, and Lanfeng Biochemical have also hit the daily limit up, while Daqo New Energy and Aiko Solar have seen increases of over 10% [1] Group 2: Industry Developments - A significant restructuring initiative in the polysilicon sector is underway, with a "joint platform" being planned for acquisition purposes [1] - The proposed "joint platform" aims to establish a fund of approximately 70 billion yuan, utilizing 10 billion yuan to facilitate a "debt acquisition" strategy [1]

Core Viewpoint - The pesticide sector experienced a significant rally on November 7, with notable stocks such as Bluefeng Biochemical hitting the daily limit up, while other companies like Lianhua Technology, Xin'an Chemical, Yangnong Chemical, Guokang Biochemical, and Limin Co. also saw increases in their stock prices [1]. Group 1 - The pesticide concept showed strong fluctuations and a notable rise in stock prices [1]. - Bluefeng Biochemical reached the daily limit up, indicating strong investor interest and confidence [1]. - Other companies in the sector, including Lianhua Technology, Xin'an Chemical, Yangnong Chemical, Guokang Biochemical, and Limin Co., also experienced stock price increases, reflecting a broader positive trend in the industry [1].

Core Viewpoint - Bluefeng Biochemical (002513) announced that neither the company nor its subsidiaries have any overdue guarantees or are involved in any litigation related to guarantees, nor are they liable for any losses due to adverse judgments related to guarantees [1] Summary by Categories - **Company Status** - Bluefeng Biochemical confirmed the absence of overdue guarantees [1] - The company and its subsidiaries are not involved in any litigation concerning guarantees [1] - There are no losses to be borne due to adverse judgments related to guarantees [1]

证券代码：002513 证券简称：蓝丰生化 公告编号：2025-068 江苏蓝丰生物化工股份有限公司 关于为控股子公司提供担保的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、对外担保情况概述 江苏蓝丰生物化工股份有限公司（以下简称"公司"）分别于 2025 年 4 月 27 日、2025 年 5 月 22 日召开公司第七届董事会第二十三次会议、2024 年年度 股东大会，审议通过了《关于预计 2025 年度为子公司提供对外担保额度的议 案》。为满足日常经营和业务发展的资金需要，公司及子公司拟为合并范围内 子公司融资事宜提供总额不超过人民币 30 亿元的担保，部分子公司资产负债率 超过 70%。担保范围包括但不限于申请综合授信、贷款、承兑汇票、信用证、 保理、保函、融资租赁、供应链融资等融资业务。具体内容详见公司于 2025 年 4 月 29 日刊登在《上海证券报》、《证券时报》、《中国证券报》和巨潮资讯 网（www.cninfo.com.cn）上的《关于预计 2025 年度为子公司提供对外担保额 度的公告》（公告编号：2025-015）。 二、担 ...

Core Viewpoint - Bluefeng Biochemical experienced a 5.43% increase in stock price, reaching 8.35 CNY per share, with a trading volume of 322 million CNY and a turnover rate of 15.13%, resulting in a total market capitalization of 2.969 billion CNY [1] Company Overview - Jiangsu Bluefeng Biochemical Co., Ltd. was established on October 11, 1990, and listed on December 3, 2010. The company is located at No. 2 Ningxia Road, Xinyi Economic Development Zone, Jiangsu [1] - The main business activities include the production and sales of pesticide raw materials and formulations, fine chemical intermediates, and pharmaceutical manufacturing [1] - The revenue composition of the main business is as follows: battery cells 43.84%, modules 31.70%, pesticide raw materials and formulations 17.20%, sulfuric acid 4.09%, other photovoltaic businesses 1.85%, and other agricultural chemical products 1.32% [1] Fund Holdings - According to data from the top ten holdings of funds, one fund under Guotai Fund has a significant position in Bluefeng Biochemical. The Guotai Juzi Quantitative Stock Selection Mixed Fund A (023386) held 8,400 shares in the third quarter, accounting for 0.87% of the fund's net value, making it the largest holding [2] - The fund has an estimated floating profit of approximately 3,612 CNY as of the report date [2] - The Guotai Juzi Quantitative Stock Selection Mixed Fund A was established on September 2, 2025, with a latest scale of 9.0448 million CNY and a cumulative return of 5.87% since inception [2] - The fund manager, Wu Kefan, has been in position for 2 years and 152 days, managing total assets of 2.092 billion CNY, with the best fund return during his tenure being 72.85% and the worst being -17.64% [2]

Group 1 - The company, Lanfeng Biochemical, responded to investor inquiries on October 29 regarding the number of shareholders, indicating that detailed information can be found in the company's periodic reports [2]